טוען...
Rituximab for Refractory Rheumatoid Arthritis: A 24-Week Open-Label Prospective Study
OBJECTIVES: To study the efficacy of rituximab in active rheumatoid arthritis (RA) patients refractory to disease modifying anti-rheumatic drugs (DMARDs) including the tumor necrosis factor (TNF)-α antagonists. METHODS: Adult patients with active RA despite adequate therapies with conventional DMARD...
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Bentham Science Publishers Ltd.
2007
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2581826/ https://ncbi.nlm.nih.gov/pubmed/19088893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874312900701010001 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|